PainChek

PainChek PEG

PEG Ratio (Price/Earnings-to-Growth) of PainChek (PCK.AX) as of Oct 18, 2026.

PEG

-

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of PainChek is 2026 - . PEG Ratio (Price/Earnings-to-Growth) of PainChek was 2025 -0.10 . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PainChek Stock analysis

What does PainChek do? PainChek Ltd, based in Sydney, Australia, operates in the Health Care sector, specializing in mobile medical device applications. The company develops and commercializes PainChek Universal, a point-of-care solution combining AI-driven facial recognition for pain assessment in non-verbal patients with the numerical rating scale for self-reporting individuals. Launched following its 2012 IPO, the technology enables objective pain evaluation across diverse care settings, supporting both non-verbal and fluctuating communication abilities. PainChek is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PainChek stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) PainChek since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s PainChek with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — PainChek

All Key Metrics — PainChek